Imipenem 500mg + Cilastatin 500mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, and Doripenem 500mg. It offers Penicillins in the form of ...

A study of 151 patients with carbapenem-nonsusceptible infections found treatment with imipenem/cilastatin/relebactam was ...

Three of these six pathogens are antibiotic-resistant Gram-negative ... However, we recently found that the CMY-10 ESBL had higher imipenem-hydrolysing activity than OXA-23, a class D ...

We surveyed local guidelines for antibiotic therapy in all French NICUs to evaluate the current local dosage ... Maintenance daily doses were significantly different among NICUs for 8 antibiotics ...

Bacterial insertion sequences (IS) are small DNA segments (<2.5 kb) with a simple genetic organization. Most IS elements exhibit short terminal inverted repeat sequences (IR) and encode a transposase, ...

in 0.45% sodium chloride injection SP 0.4 mL/min Imipenem Merck 3726J 500 mg (5 mg/mL) in 0.9% sodium chloride injection IV 100 mL/hr Ketorolac Abbott 47359DK 30 mg (15 mg/mL) IVP over 20 sec ...

Keywords: imipenem, population pharmacokinetics, dosing optimization, elderly patients, Monte Carlo Citation: Wang J, Fang Q, Luo X, Jin L and Zhu H (2025) Corrigendum: Population pharmacokinetics and ...

The high incidence of culture-positive sepsis, case-fatality rates, and multidrug resistance among common pathogens underscores an urgent need to strengthen infection prevention and control practices, ...

Patients and interventions: 327 ambulatory patients diagnosed with radio-graphically confirmed community-acquired pneumonia administered clarithromycin 500mg immediate-release or amoxicillin ...

The number of measles cases in an outbreak in the South Plains region of northern Texas has grown from 24 illnesses to 48 in ...

Background Antibiotic resistance is a growing problem worldwide, but communicating this challenge to policymakers and non-experts is complicated by the multiplicity of bacterial pathogens and the ...